Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 11467371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The absorption of vitamin B12 during treatment with para-aminosalicylic acid.

  2009cited by this paper
• Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

  2000cited by this paper
• Managerial successes, clinical failures.

  1999cited by this paper
• Managerial successes, clinical failures.

  1999cited by this paper
• The dilemma of MDR-TB in the global era.

  1998cited by this paper
• The global threat of drug-resistant tuberculosis.

  1998cited by this paper
• Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”

  1998cited by this paper
• Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  1998cited by this paper
• Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.

  1997cited by this paper
• Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease.

  1997cited by this paper
• Nosocomial multidrug-resistant tuberculosis--global spread of the third epidemic.

  1997cited by this paper
• A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.

  1996cited by this paper
• Multidrug resistance in the world: the present situation.

  1996cited by this paper
• Hepatotoxic effects of tuberculosis therapy.

  1996cited by this paper
• Frequency and type of reactions to antituberculosis drugs: observations in routine treatment.

  1996cited by this paper
• Hepatotoxic effects of tuberculosis therapy. A practical approach to a tricky management problem.

  1996cited by this paper
• Improved outcomes for patients with multidrug-resistant tuberculosis.

  1995cited by this paper
• Anti-tuberculosis medication and the liver: dangers and recommendations in management.

  1995cited by this paper
• Tolerability of Fluoroquinolone Antibiotics

  1995cited by this paper
• Avoidance and Management of Adverse Reactions to Antituberculosis Drugs

  1995cited by this paper
• Multidrug-resistant tuberculosis in patients without HIV infection.

  1995cited by this paper
• Predictors and outcome of multidrug-resistant tuberculosis.

  1995cited by this paper
• Aminoglycosides.

  1995cited by this paper
• Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

  1993cited by this paper
• Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.

  1993cited by this paper
• Treatment of multidrug-resistant tuberculosis.

  1993cited by this paper
• PITFALLS IN THE CARE OF PATIENTS WITH TUBERCULOSIS: COMMON ERRORS AND THEIR ASSOCIATION WITH THE ACQUISITION OF DRUG RESISTANCE

  1993cited by this paper
• Treatment of multidrug-resistant tuberculosis

  1993cited by this paper
• Pharmacology of the antimycobacterial drugs.

  1993cited by this paper
• Isoniazid-associated hepatitis deaths: a review of available information.

  1992cited by this paper
• USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.

  1990cited by this paper
• Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

  1990cited by this paper
• Study on hepatotoxicity and other side-effects of antituberculosis drugs.

  1990cited by this paper
• Drug-resistant tuberculosis.

  1989cited by this paper
• Current tuberculosis treatment regimens. Choosing the right one for your patient.

  1989cited by this paper
• Determinants of efficacy and toxicity of aminoglycosides.

  1989cited by this paper
• The prevention and management of drug-resistant tuberculosis.

  1987cited by this paper
• Neurological Manifestations and Toxicities of the Antituberculosis Drugs

  1987cited by this paper
• Clinical Pharmacokinetics of the Antituberculosis Drugs

  1984cited by this paper
• The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.

  1984cited by this paper
• Ethionamide-induced goitrous hypothyroidism.

  1984cited by this paper
• Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.

  1984cited by this paper
• Ethambutol-induced hyperuricaemia.

  1984cited by this paper
• A review of side-effects experienced by patients taking clofazimine.

  1983cited by this paper
• Adverse effects of antituberculosis drugs causing changes in treatment.

  1982cited by this paper
• Pyridoxine supplementation during isoniazid therapy.

  1980cited by this paper
• Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.

  1980cited by this paper
• Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment.

  1979cited by this paper
• Effect of ethionamide on thyroid function.

  1976cited by this paper
• Effect of ethionamide on thyroid function.

  1976cited by this paper
• Side effects of drugs used to treat tuberculosis.

  1975cited by this paper
• Side effects of drugs used to treat tuberculosis.

  1975cited by this paper
• Isoniazid: a review with emphasis on adverse effects.

  1972cited by this paper
• Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.

  1970cited by this paper
• A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis.

  1970cited by this paper
• Side effects of cycloserine.

  1970cited by this paper
• Psychosomatic reactions to cycloserine in the treatment of tuberculosis.

  1970cited by this paper
• Neurologic and behavioural reactions of tuberculous patients treated with cycloserine.

  1970cited by this paper
• Influence of capreomycin on renal function. (Preliminary results).

  1970cited by this paper
• Studies on goitre due to para-aminosalicylic acid.

  1969cited by this paper
• Steatorrhea induced by para-aminosalicylic acid.

  1968cited by this paper
• Multiple-drug reactions in tuberculosis--an illustrative case.

  1968cited by this paper
• Para-aminosalicylic acid as a cause of intestinal malabsorption.

  1968cited by this paper
• Isoniazid hypersensitivity reaction involving the eyes. Report of a case.

  1967cited by this paper
• Psychotoxic reaction during ethionamide therapy.

  1967cited by this paper
• THE AUDITORY, VESTIBULAR AND RENAL EFFECTS OF CAPREOMYCIN IN HUMANS

  1966cited by this paper
• Peripheral neuropathy due to ethioniamide.

  1961cited by this paper
• The anti-thyroid action of para-aminosalicylic acid.

  1954cited by this paper
• The mechanism of the goitrogenic action of p-aminosalicylic acid.

  1954cited by this paper
• Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid (rimifon, marsilid).

  1952cited by this paper

• Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan

  2024influential citation
• Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon

  2023cites this paper
• Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda

  2023cites this paper
• Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study

  2022influential citation
• Minimizing nephrotoxicity during multidrug-resistant tuberculosis treatment by the stepwise de-escalation of second-line injectables dosing intervals.

  2022cites this paper
• Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India

  2022cites this paper
• A Score to Predict the Risk of Major Adverse Drug Reactions Among Multi-Drug Resistant Tuberculosis Patients in Southern Ethiopia, 2014–2019

  2022cites this paper
• Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study

  2022cites this paper
• A study of adverse drug reactions in patients receiving treatment for multidrug-resistant tuberculosis in a tertiary care center

  2022cites this paper
• Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan

  2022cites this paper
• Incidence of adverse drug events among patients on second line anti-tuberculosis regimen in the littoral region of cameroon

  2021cites this paper
• Frequency and type of adverse drug reactions related to multidrug-resistant tuberculosis therapy

  2021cites this paper
• Psychosis During Multidrug Resistant Tuberculosis Treatment: A Case Report

  2020cites this paper
• Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

  2019influential citation
• Drug-Resistant Tuberculosis and HIV

  2019cites this paper
• Assessment of Baseline Biochemical Thyroid Function in Patients with MultiDrug Resistant Tuberculosis in Maiduguri

  2019cites this paper
• HIV and Tuberculosis: A Formidable Alliance

  2019cites this paper
• Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis.

  2019cites this paper
• Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.

  2019cites this paper
• TO ASSESS THE ADVERSE EFFECT PROFILE OF SECOND LINE DRUG IN TB PATIENTS

  2019cites this paper
• Treatment outcome of multidrug-resistant tuberculosis with modified DOTS-plus strategy: A 2 years' experience

  2019cites this paper
• Evaluation of cases of pediatric extrapulmonary tuberculosis: a single center experience

  2019cites this paper
• Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola.

  2019cites this paper
• Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy

  2019cites this paper
• Long term follow-up of multidrug resistant tuberculosis in a pubertal child

  2018cites this paper
• Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.

  2018cites this paper
• Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis–Human Immunodeficiency Virus Coinfection in South Africa

  2018cites this paper
• Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.

  2018influential citation
• Severe Adverse Effects Associated with Multidrug Resistant Tuberculosis Medications among Patients attending ALERT Hospital, Ethiopia.

  2018cites this paper
• Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children

  2018cites this paper
• A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of MDR-TB at tertiary care hospital

  2018cites this paper
• Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis

  2018cites this paper
• Does the Drug Exposure of Aminoglycosides in the Treatment of Tuberculosis relate to Efficacy and Toxicity?

  2018cites this paper
• Strengthening the Delivery and Improving Outcomes of Drug-Resistant TB Treatment through Rational Medication Use Review

  2018cites this paper
• PREVALENCE OF DEPRESSION AMONG NEWLY DIAGNOSED MDR TUBERCULOSIS PATIENTS AT THE TIME OF REGISTRATION- AN EXPERIENCE FROM DOTS PLUS CENTRE

  2018cites this paper
• Effects of Injectable Aminoglycosides on the Auditory Performance of Individuals with Drug Resistant Tuberculosis in Osun State, Nigeria

  2018cites this paper
• Recent controversies about MDR and XDR‐TB: Global implementation of the WHO shorter MDR‐TB regimen and bedaquiline for all with MDR‐TB?

  2018cites this paper
• Impact of Adverse Reactions on Adherence To Treatment For Mdr –Tb Under Pmdt in A Tertiary Care Teaching Hospital

  2017cites this paper
• SIDE EFFECTS ASSOCIATED WITH DRUGS USED IN TREATMENT OF MULTI DRUG RESISTANT TUBERCULOSIS AND TREATMENT RELATED FACTORS OF MULTI DRUG RESISTANT TUBERCULOSIS PATIENTS IN KATHMANDU VALLEY

  2017cites this paper
• Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal

  2017cites this paper
• Peptide nucleic acids (PNAs): currently potential bactericidal agents.

  2017cites this paper
• Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.

  2017cites this paper
• The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?

  2017cites this paper
• Optimizing the Safety of Multidrug-resistant Tuberculosis Therapy in Namibia

  2017influential citation
• Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.

  2017cites this paper
• Clinical Management of Multidrug‐Resistant Tuberculosis

  2017cites this paper
• Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.

  2017cites this paper
• Imaging Findings of Tuberculosis of the Cranial and Peripheral Nerves

  2017cites this paper
• Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study

  2017cites this paper
• Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea

  2017influential citation
• Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients

  2017cites this paper
• Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis

  2016cites this paper
• Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients

  2016cites this paper
• Adverse Reactions Due to Directly Observed Treatment Short Course Therapy: An Indian Prospective Study

  2016cites this paper
• Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

  2016cites this paper
• Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.

  2016cites this paper
• Tuberculose multirésistante chez l'enfant: à propos de deux cas

  2016cites this paper
• Elucidating the role of clofazimine for the treatment of tuberculosis.

  2016cites this paper
• A Study of Adverse Drug Reactions Caused by Second Line Anti-Tubercular Drugs Used In Nepal. -

  2016cites this paper
• The safety and tolerability of the second-line injectable antituberculosis drugs in children

  2016cites this paper
• Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.

  2016cites this paper
• Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in namibia

  2016cites this paper
• Pharmacovigilance analysis in a rural tertiary care hospital in North India: a retrospective study -

  2016cites this paper
• Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review

  2016influential citation
• Adverse reactions among patients being treated for multi-drug resistant tuberculosis in Egypt from July 2006 to January 2009

  2015cites this paper
• Adverse Drug Reactions in Management of Multi Drug Resistant Tuberculosis, in Tertiary Chest Institute

  2015influential citation
• Peripheral neuropathy in persons with tuberculosis

  2015cites this paper
• Multidrug-resistant tuberculosis: Need for better diagnostic modalities and clinical end points – Five-year tertiary care hospital experience

  2015cites this paper
• Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital

  2015cites this paper
• Hypothyroidism in MDR-TB treatment – Rare occurrence but a major concern

  2015cites this paper
• Assessment of hearing loss in multi-drug resistant tuberculosis (MDR-TB) patients undergoing Aminoglycoside treatment

  2015cites this paper
• Adverse Events in Treating Smear-Positive Tuberculosis Patients in China

  2015cites this paper
• ADVERSE DRUG REACTIONS AND RESULTANT HEALTH-RELATED QUALITY OF LIFE DURING MULTIDRUG-RESISTANT TUBERCULOSIS TREATMENT IN SOUTH AFRICA

  2015cites this paper
• Comparative Analysis of Adverse Drug Reactions in Directly Observed Treatment Short Course (DOTS) in TB Patients

  2014cites this paper
• Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients

  2014cites this paper
• Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature

  2014cites this paper
• A Prospective, Observational Study of Adverse Reactions to Drug Regimen for Multi-Drug Resistant Pulmonary Tuberculosis in Central India

  2014cites this paper
• Treatment outcomes for patients with multidrug-resistant tuberculosis in post-earthquake Port-au-Prince, Haiti.

  2014cites this paper
• OCCURRENCE AND PROPORTIONAL ANALYSIS OF ADVERSE DRUG REACTIONS IN DOTS PLUS

  2014cites this paper
• Chapter 12 Management of Drug-Resistant TB

  2013cites this paper
• Adverse Events in an Integrated Home-Based Treatment Program for MDR-TB and HIV in KwaZulu-Natal, South Africa

  2013cites this paper
• Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

  2013cites this paper
• 2808 – A Review of the Interplay Between Tuberculosis and Mental Health

  2013cites this paper
• Multi drug and extensively drug-resistant TB (M/XDR-TB) management: Current issues

  2013cites this paper
• Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011.

  2013cites this paper
• Management of Drug-Resistant TB

  2013cites this paper
• Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania

  2013cites this paper
• Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection

  2013cites this paper
• Évaluation du traitement de la tuberculose multi-résistante en Côte d’Ivoire de 2008 à 2010

  2013cites this paper
• Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients

  2013cites this paper
• Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

  2013cites this paper
• [Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010].

  2013cites this paper
• TSH-CHECK-1 Test: Diagnostic Accuracy and Potential Application to Initiating Treatment for Hypothyroidism in Patients on Anti-Tuberculosis Drugs

  2012cites this paper
• Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future

  2012cites this paper
• Adverse event Grade 1 : mild Grade 2 : moderate Grade 3 : severe Grade 4 : life threatening

  2012cites this paper
• Multidrug Resistant Tuberculosis; a Pharmacological view based on Revised National Tuberculosis Control Programme DOTS-Plus Guidelines.

  2012cites this paper
• Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India

  2012cites this paper
• Prevalence of hypothyroidism among MDR-TB patients in Botswana.

  2012cites this paper
• A description of the hearing profile in gold miners with tuberculosis

  2012cites this paper
• Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis.

  2012cites this paper